Pathological survivin expression links viral infections with pathogenesis of erosive rheumatoid arthritis

被引:18
作者
Bokarewa, M. [1 ]
Tarkowski, A. [1 ]
Magnusson, M. [1 ]
机构
[1] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Sahlgrens Univ Hosp, S-41346 Gothenburg, Sweden
关键词
D O I
10.1111/j.1365-3083.2007.01977.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Rheumatoid arthritis (RA) is an inflammatory joint disease leading to cartilage and bone destruction. Insufficient apoptosis in the inflamed RA synovium along with accumulation of highly differentiated B- and T-lymphocytes as well as invasive growth of macrophages and fibroblasts is among the major mechanisms supporting joint destruction. We have recently shown that circulating survivin, an apoptotis inhibitor tightly bound to tumorigenesis, is an independent predictor of development and progression of joint destruction in RA. In this review we discuss the possible connectivity between viral infection, leading to interferon (IFN)-alpha production, survivin expression, and subsequent joint inflammation. The role of IFN-a and the involvement of IFN transcription factors and phosphoinositide-3-kinase signalling as essential modulators of arthritogenic process are discussed in the context of survivin.
引用
收藏
页码:192 / 198
页数:7
相关论文
共 70 条
[1]   Regulation of Survivin and CDK4 by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cell lines [J].
Ai, MD ;
Li, LL ;
Zhao, XR ;
Wu, Y ;
Gong, JP ;
Cao, Y .
CELL RESEARCH, 2005, 15 (10) :777-784
[2]   Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].
Alexopoulou, L ;
Holt, AC ;
Medzhitov, R ;
Flavell, RA .
NATURE, 2001, 413 (6857) :732-738
[3]   Survivin, versatile modulation of cell division and apoptosis in cancer [J].
Altieri, DC .
ONCOGENE, 2003, 22 (53) :8581-8589
[4]   Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells [J].
Asanuma, H ;
Torigoe, T ;
Kamiguchi, K ;
Hirohashi, Y ;
Ohmura, T ;
Hirata, K ;
Sato, M ;
Sato, N .
CANCER RESEARCH, 2005, 65 (23) :11018-11025
[5]  
Aupperle KR, 1998, AM J PATHOL, V152, P1091
[6]   What are the links between Epstein-Barr virus, lymphoma, and tumor necrosis factor antagonism in rheumatoid arthritis? [J].
Balandraud, N ;
Roudier, J ;
Roudier, C .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2005, 34 (05) :31-33
[7]   Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis [J].
Bokarewa, M ;
Lindblad, S ;
Bokarew, D ;
Tarkowski, A .
ARTHRITIS RESEARCH & THERAPY, 2005, 7 (02) :R349-R358
[8]   Survivin promoter polymorphism and cervical carcinogenesis [J].
Borbely, A. A. ;
Murvai, M. ;
Szarka, K. ;
Konya, J. ;
Gergely, L. ;
Hernadi, Z. ;
Veress, G. .
JOURNAL OF CLINICAL PATHOLOGY, 2007, 60 (03) :303-306
[9]   Survivin as a marker of cervical intralepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer [J].
Branca, M ;
Giorgi, C ;
Santini, D ;
Di Bonito, L ;
Ciotti, M ;
Costa, S ;
Benedetto, A ;
Casolati, EA ;
Favalli, C ;
Paba, P ;
Di Bonito, P ;
Mariani, L ;
Syrjänen, S ;
Bonifacio, D ;
Accardi, L ;
Zanconati, F ;
Syrjänen, K .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 124 (01) :113-121
[10]  
Brennan FM, 2002, ARTHRITIS RHEUM, V46, P31, DOI 10.1002/1529-0131(200201)46:1<31::AID-ART10029>3.0.CO